Search for: "Hospira" Results 41 - 60 of 487
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Jun 2015, 3:50 am
 So it is with slight delay that the IPKat comes to the latest decision in the apparently endless Hospira v Genentech saga. [read post]
23 Apr 2012, 2:21 pm
Hospira reported worldwide sales for 2011 as just over $4.1 billion, and products manufactured by Hospira are used in clinics and hospitals around the world. [read post]
21 Jan 2011, 10:27 am by Jeff Gamso
  For Ohio, like for Hospira, it would be good business. [read post]
29 Jul 2016, 10:00 am
The Court of Appeal handed down its decision yesterday in Hospira v Genentech (with the first instance decision reported by this Kat here). [read post]
13 Nov 2015, 11:35 am by Lawrence B. Ebert
Giventhat Hospira, Inc. was the original cross-appellant on theissues to be addressed, Hospira, Inc. [read post]
28 Sep 2010, 2:52 pm by Jesse
Hospira Inc. is the company that 35 states use for lethal injections executions. [read post]
7 Feb 2011, 4:30 am by Laura Simons
It is expected, in light of Hospira's recent statement, that most states will now follow Oklahoma's lead in seeking similar approvals of the substitute drug.The news of Hospira's decision has reignited debates online about the merits of capital punishment. [read post]
17 Dec 2019, 4:15 am by Nancy Braman
Patent No. 5,856,298 (the ‘298 patent) belonging to Amgen was infringed by Hospira and not invalid; 2) 14 batches of drug substance for Hospira’s erythropoietin biosimilar drug product were not covered by the Safe Harbor provision of 35 USC § 271(e)(1); and 3) Amgen had proven that it was entitled to a jury verdict of $70 million in... [read post]
30 Apr 2009, 9:09 am
  The lawsuit stems from Abbott Laboratories spinoff into a separate company, Hospira, which is also named in the suit. [read post]
2 Jul 2015, 12:06 pm by Lawrence B. Ebert
Hospira, Inc. cross-appeals the district court’s determination that the assert-ed claims are not invalid under the on-sale bar, obvious-ness, or indefiniteness.We conclude that the district court clearlyerred in finding that the bivalirudin batchesprepared by Ben Venue Laboratories before the criticaldate were not sold to The Medicines Company andwere prepared primarilyfor an experimental purpose. [read post]
3 Jun 2012, 8:34 pm by Patent Docs
Hospira Inc. 1:12-cv-00652; filed May 23, 2012 in the District Court of Delaware • Plaintiffs: Astellas US LLC; Astellas Pharma US, Inc.; Item Development AB • Defendant: Hospira Inc. [read post]
4 Jun 2010, 9:39 am by By STEVEN M. DAVIDOFF
The Deal Professor examines the lawsuit by Javelin Pharmaceuticals against its agreed acquirer, Hospira, in light of the tricky issues surrounding efforts to end the deal. [read post]
25 Sep 2021, 9:04 pm by Patent Docs
Hospira" on September 27, 2021 from 12:00 pm to 1:30 pm (CT). [read post]